Does SIPULEUCEL-T Cause Hospitalisation? 95 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Hospitalisation have been filed in association with SIPULEUCEL-T (PROVENGE). This represents 2.1% of all adverse event reports for SIPULEUCEL-T.
95
Reports of Hospitalisation with SIPULEUCEL-T
2.1%
of all SIPULEUCEL-T reports
9
Deaths
95
Hospitalizations
How Dangerous Is Hospitalisation From SIPULEUCEL-T?
Of the 95 reports, 9 (9.5%) resulted in death, 95 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPULEUCEL-T. However, 95 reports have been filed with the FAERS database.
What Other Side Effects Does SIPULEUCEL-T Cause?
Chills (447)
Infusion related reaction (414)
Pyrexia (255)
Fatigue (249)
Malaise (233)
Nausea (205)
Disease progression (185)
Ill-defined disorder (185)
Culture positive (174)
Asthenia (164)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which SIPULEUCEL-T Alternatives Have Lower Hospitalisation Risk?
SIPULEUCEL-T vs SIROLIMUS
SIPULEUCEL-T vs SIRUKUMAB
SIPULEUCEL-T vs SITAGLIPTIN
SIPULEUCEL-T vs SOAP
SIPULEUCEL-T vs SODIUM